We are delighted to announce that we are now a member of the UK BioIndustry Association (BIA).
The BIA is at the forefront of UK bioscience, serving as its voice, connecting individuals and organisations, from SMEs, including innovative start-ups, to multi-national companies, helping to shape the future of the sector.
Members are responsible for over 90% of biotech medicines currently in clinical development in the UK. In the last year, BIA members have taken forward pioneering research such as the first stem cell therapy clinical trials for stroke and the first drug to delay bone metastases in cancer.
The BIA pushes for progress in UK bioscience on every front. The goal is to ultimately deliver the best possible environment for growth and innovation.